About Us
CONTACT US
Tel: +86-576-88708516, 88708517,88708518(Taizhou Office)
Fax: +86-576-88708519 (Taizhou Office)
Contact:
Mr. Yu : +86-13806578373 ;
Mr. Lu : +86-15990601833
E-mail : sales@jinquanpharm.com
Anhui Jinquan Biotechnology Limited Liability Company (primary Anqing Jinquan Pharmaceutical Co., Ltd.) was founded in 2005. Our company is located in Wangjiang Leichi Industrial Park in beautiful Anhui. Our company covers an area of 80mu, including construction area of more than 22000 square meters. It is a private science and technology enterprise integrated of production, research and marketing. Through ten years of development, our company has accumulated assets of RMB 50 million Yuan. We have gained fine social benefit and economic benefit.
In November, 2014, our company completed shareholding reform and registered Anhui Jinquan Biotechnology Limited Liability Company.
At 10th, June, 2015, our company started public listing on the stock market, which is development foundation for future.
In 2005, Anqing Jinquan Pharmaceutical Co., Ltd. (hereafter referred as Jinquan Technology) started its business under invitation of Anhui Wangjiang County People’s Government. Our company always insists on principle of “good faith, mutual-benefit and joint development”. We cooperate closely with scientific research institutions, for example, Shanghai Institute of Materia Medica, China Pharmaceutical University, Zhejiang University, Zhejiang University of Technology, Huanggang Normal University, and great achievement has been gained through cooperation. We make efforts to develop new products and upgrade old products in order to promote our competitiveness and to seize market share.
In past ten years, Anhui Jinquan Technology emphasizes on cultivation of innovation capacity. We invest millions on establishment of research and development center. We invite dozen of top talents in chemical field with innovation capacity. We bring new ideas into 15 scientific payoffs, such as, amorphous technique of atorvastatin calcium and synthesis technique of Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate. What’s more, we have gained national patents of invention. At present, there are 108 permanent staffs, 7 manufacturing workshops and over 900 sets of equipment. Our R&D center is equipped with precise instrument required for research. Main products are atorvastatin calcium, a new drug for reducing blood fat, and intermediate of Etodolac. Atorvastatin calcium is widely applied drug for reducing of blood fat with advantages of low dosage but fine curative effect. Etodolac is a kind of non-steroidal anti-inflammatory drug with fine orally absorption effect. With increasing demand on atorvastatin calcium, our MI product is becoming more and more popular among large companies in the whole world due to high performance ratio. And it has become international famous brand. Jinquan Technology has gained independent rights for import and export. Since then, our products are highly regarded by large pharmaceutical enterprises in America, Germany, Britain, Switzerland, Portland, Israel, India and Japan relying on high quality, reasonable price and complete service. M4, key product of our company, has been improved greatly through technique innovation. Its quality and cost are both at competitive level in this industry.
In addition, Anhui Jinquan Biotechnology Limited Liability Company continuously strengthens interior management and promotes staff’s quality. Complete and modern management system has been formed; quality management system and metrical information management network have been strengthened. Our company passed WSC international standard authentication, ISO9000 quality system authentication and CAS14000 environmental system authentication. In past years, our company has been awarded of “new and high-tech enterprise” by Ministry of Science and Technology, Provincial Department of Science and Technology, and Municipal Science and Technology Bureau.
The R&D Center was praised as “municipal enterprise technology center” by Anqing People’s Government and our company was praised as “Anqing Advanced Innovation Enterprise” in 2011.
In 2012, we gained honors of “Provincial Enterprise Technology Center”, “Anhui Private Technology Enterprise”, “Anqing Credit Trustworthy Enterprise”, “Anqing Advanced Enterprise for Import and Export”, “Top 10 Enterprises of Wangjiang County”.
In future, Jinquan Technology will speed up in industrial adjustment and upgrading according to “the 12th Five-Year Plan” and practical condition. We will explore how to expand domestic market.
In 2014, our company invested RMB 40 million Yuan to construct Jiangxi Yuanbang Pharmaceutical and Medical Material research, production and selling project (1st stage project is under installation and debugging) to enlarge the production and expand new research field. Our company is determined to promote product quality.
Our target in 2017 is to realize annual sales revenues of 160 million Yuan. And the profit will break through 25 million Yuan. It is planned that annual value of production will reach 500 million Yuan and taxation of profit will pass 80 million Yuan in 2020.
In capital market aspect, our company introduced private equity before reform of non-tradable shares. Therefore we implemented private placement twice. Currently, our company is under negotiation with securities traders and investment companies. Our company will become bigger and stronger in future.